CellTran

About:

CellTran is a biotechnology company engaged in the development of cell therapy products for the wound management industry.

Website: http://www.celltran.com

Top Investors: YFM Equity Partners, Innogenetics, SMH Venture Finance Limited, Partnerships UK, Spirit Capital Partners

Description:

CellTran Limited engages in the research and development of products for the regeneration of tissue and the healing of wounds. The company offers Myskin that is used for the treatment of difficult to heal wounds; Lyphoderm, a freeze-dried lysate from cultured human keratinocytes that is formulated into a hydrophilic gel; and Ulcodress, an integrated wound care dressing that provides control of moisture, infection, and proteases within the wound area. It provides skin banking services, as well as contract manufacture services in the fields of materials fabrication and cell culture. The company was founded in 2000 and is based in Sheffield, the United Kingdom. As of October 28, 2008, CellTran Limited operates as a subsidiary of York Pharma plc.